<DOC>
	<DOCNO>NCT01668199</DOCNO>
	<brief_summary>A study investigate mass balance recovery pharmacokinetics 14C TZP-101 .</brief_summary>
	<brief_title>A Study Healthy Male Subjects Designed Assess Mass Balance Recovery Pharmacokinetics 14C TZP-101</brief_title>
	<detailed_description />
	<criteria>Healthy Males 3565 year age Body Mass Index ( BMI ) 1832 kg/m2 , outside range , consider clinically significant investigator Body weight 7590kg Must willing able communicate participate whole study Must provide write informed consent Subject must agree use adequate method contraception Participation clinical research study within previous 3 moth 3 study within previous 12 month Participation ADE study within previous 12 month History drug alcohol abuse past 2 year Regular alcohol consumption &gt; 21 unit per week Current smoker smoke within last 12 month , breath carbon monoxide ( CO ) reading great 10ppm screen Radiation exposure clinical study , include present study , exclude background radiation include diagnostic Xrays medical exposure , exceed 5 mSv last twelve month 10 mSv last 5 year . No occupationally expose worker , define Ionising Radiation Regulations 1999 , shall participate study Clinically significant abnormal biochemistry , haematology urinalysis screen judge investigator Clinically significant abnormal physical finding , ECG vital sign measurement screen PR interval 220 m screen admission QTcB &gt; 450 m screen admission Existence surgical medical condition might interfere absorption , distribution , metabolism excretion IMP History presence significant cardiovascular , respiratory , gastrointestinal ( especially peptic ulcer disease ) , neurological , psychiatric , metabolic , hepatic renal problem judge investigator Positive drug abuse test result Positive HBV , HCV HIV result Use prescription non prescription drug , include vitamin , herbal dietary supplement ( include St. John 's Wort ) within 14 day plan IMP administration unless opinion PI medication interfere study procedure compromise study safety Serious adverse reaction serious hypersensitivity drug formulation excipients Presence history allergy require treatment ( seasonal allergic rhinitis ( hayfever ) allow unless active ) Donation loss great 400 mL blood within previous three month Subjects receive require prohibit medication describe Section 11 Failure satisfy Investigator fitness participate reason Poor venous access</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>